# Randomized Study of Letrozole and Trilostane for Medical Abortion

> **NCT01615211** · PHASE2 · TERMINATED · sponsor: **Kristina Gemzell Danielsson** · enrollment: 36 (estimated)

## Conditions studied

- Medical Abortion, Complete or Unspecified, Without Complication

## Interventions

- **DRUG:** Letrozole
- **DRUG:** Trilostane

## Key facts

- **NCT ID:** NCT01615211
- **Lead sponsor:** Kristina Gemzell Danielsson
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 36 (ESTIMATED)
- **Why stopped:** No access to study drug Trilostan. Company closed down
- **Last updated:** 2015-05-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01615211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01615211, "Randomized Study of Letrozole and Trilostane for Medical Abortion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01615211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*